Atea Pharmaceuticals, Inc. (AVIR) vs Prothena Corporation plc (PRTA)

A side-by-side comparison of Atea Pharmaceuticals, Inc. and Prothena Corporation plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVIR vs PRTA

growth of $100 · dividends reinvested · last 6y
AVIR -83.1% (-25.6%/yr)PRTA -26.6% (-5.0%/yr)PRTA compounded faster over this window
0200400600Start $100202120222023202420252026$17$73
AVIR PRTA

AVIR vs PRTA: by the numbers

  • •PRTA is the larger company ($414M vs $407M market cap).
  • •Both run net losses; AVIR's is the smaller (0.00% vs -80.67% net margin).

Metrics side by side

Valuation

MetricAVIRPRTA
Forward P/EN/A71.82
P/S ratioN/A7.58
P/B ratio1.991.44

Profitability

MetricAVIRPRTA
Gross margin0.00%61.77%
Operating margin0.00%-1905.82%
Net margin0.00%-80.67%
ROE-80.96%-15.33%
ROIC-89.93%-21.36%

Growth (annualized)

MetricAVIRPRTA
Revenue CAGR (5Y)N/A62.57%
Total return CAGR (5Y)-34.44%-35.08%

Frequently asked

How have AVIR and PRTA total returns compared?
Over the past 5 years, AVIR delivered -34.44% and PRTA delivered -35.08% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.